| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |